Generation Bio (GBIO) Competitors $6.01 +0.03 (+0.50%) Closing price 09/11/2025 04:00 PM EasternExtended Trading$6.02 +0.00 (+0.08%) As of 09/11/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GBIO vs. NKTX, SCLX, CABA, LFVN, MIST, AVTX, THTX, CHRS, GLSI, and CLLSShould you be buying Generation Bio stock or one of its competitors? The main competitors of Generation Bio include Nkarta (NKTX), Scilex (SCLX), Cabaletta Bio (CABA), Lifevantage (LFVN), Milestone Pharmaceuticals (MIST), Avalo Therapeutics (AVTX), Theratechnologies (THTX), Coherus Oncology (CHRS), Greenwich LifeSciences (GLSI), and Cellectis (CLLS). These companies are all part of the "pharmaceutical products" industry. Generation Bio vs. Its Competitors Nkarta Scilex Cabaletta Bio Lifevantage Milestone Pharmaceuticals Avalo Therapeutics Theratechnologies Coherus Oncology Greenwich LifeSciences Cellectis Generation Bio (NASDAQ:GBIO) and Nkarta (NASDAQ:NKTX) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, valuation, earnings, profitability, analyst recommendations, dividends, institutional ownership and media sentiment. Which has more volatility and risk, GBIO or NKTX? Generation Bio has a beta of 2.48, meaning that its stock price is 148% more volatile than the S&P 500. Comparatively, Nkarta has a beta of 0.76, meaning that its stock price is 24% less volatile than the S&P 500. Does the media prefer GBIO or NKTX? In the previous week, Nkarta had 2 more articles in the media than Generation Bio. MarketBeat recorded 4 mentions for Nkarta and 2 mentions for Generation Bio. Generation Bio's average media sentiment score of 1.89 beat Nkarta's score of 1.75 indicating that Generation Bio is being referred to more favorably in the media. Company Overall Sentiment Generation Bio Very Positive Nkarta Very Positive Do institutionals and insiders have more ownership in GBIO or NKTX? 95.2% of Generation Bio shares are owned by institutional investors. Comparatively, 80.5% of Nkarta shares are owned by institutional investors. 21.8% of Generation Bio shares are owned by insiders. Comparatively, 8.4% of Nkarta shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Do analysts recommend GBIO or NKTX? Generation Bio presently has a consensus price target of $10.67, indicating a potential upside of 77.48%. Nkarta has a consensus price target of $13.60, indicating a potential upside of 557.00%. Given Nkarta's stronger consensus rating and higher possible upside, analysts plainly believe Nkarta is more favorable than Generation Bio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Generation Bio 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67Nkarta 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has higher earnings and valuation, GBIO or NKTX? Nkarta has lower revenue, but higher earnings than Generation Bio. Nkarta is trading at a lower price-to-earnings ratio than Generation Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGeneration Bio$19.89M2.04-$131.67M-$10.82-0.56NkartaN/AN/A-$108.79M-$1.48-1.40 Is GBIO or NKTX more profitable? Nkarta has a net margin of 0.00% compared to Generation Bio's net margin of -341.12%. Nkarta's return on equity of -27.74% beat Generation Bio's return on equity.Company Net Margins Return on Equity Return on Assets Generation Bio-341.12% -91.07% -33.65% Nkarta N/A -27.74%-22.38% SummaryNkarta beats Generation Bio on 10 of the 16 factors compared between the two stocks. Get Generation Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GBIO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GBIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GBIO vs. The Competition Export to ExcelMetricGeneration BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$40.28M$3.15B$5.78B$10.07BDividend YieldN/A2.32%5.69%4.62%P/E Ratio-0.5621.6075.3726.21Price / Sales2.04297.80471.1491.59Price / CashN/A45.3337.0859.91Price / Book0.479.7111.906.28Net Income-$131.67M-$53.33M$3.29B$270.85M7 Day Performance0.33%1.04%1.49%3.58%1 Month Performance48.40%9.93%7.72%6.67%1 Year Performance-76.25%13.80%59.32%27.73% Generation Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GBIOGeneration Bio4.1982 of 5 stars$6.01+0.5%$10.67+77.5%-75.4%$40.28M$19.89M-0.56150Positive NewsShort Interest ↓NKTXNkarta2.3437 of 5 stars$2.12-6.2%$13.60+541.5%-67.8%$160.51MN/A-1.43140Positive NewsHigh Trading VolumeSCLXScilex2.1151 of 5 stars$22.17-2.8%$455.00+1,952.3%-33.5%$158.59M$56.59M-0.7680Positive NewsCABACabaletta Bio3.1429 of 5 stars$1.68-1.2%$14.50+763.1%-57.5%$155.49MN/A-0.6250News CoverageLFVNLifevantage4.0353 of 5 stars$11.44-5.5%$30.50+166.6%+24.5%$153.69M$228.53M15.46260High Trading VolumeMISTMilestone Pharmaceuticals2.8456 of 5 stars$1.75-2.8%$5.00+185.7%+31.7%$152.99M$1M-2.0830News CoveragePositive NewsAnalyst ForecastAVTXAvalo Therapeutics3.8216 of 5 stars$11.41-1.6%$30.00+162.9%+32.7%$152.57M$440K0.0040Positive NewsShort Interest ↓THTXTheratechnologiesN/A$3.27flatN/A+166.7%$150.35M$85.87M-17.21140Short Interest ↓CHRSCoherus Oncology4.2338 of 5 stars$1.37+6.2%$4.51+229.4%+0.0%$149.93M$272.21M0.88330GLSIGreenwich LifeSciences1.5511 of 5 stars$11.17+2.2%$42.00+276.0%-18.2%$148.98MN/A-8.213Trending NewsCLLSCellectis3.31 of 5 stars$2.74+2.2%$4.00+46.0%+31.3%$148.96M$49.22M-3.34290Positive NewsShort Interest ↓Gap Up Related Companies and Tools Related Companies NKTX Alternatives SCLX Alternatives CABA Alternatives LFVN Alternatives MIST Alternatives AVTX Alternatives THTX Alternatives CHRS Alternatives GLSI Alternatives CLLS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GBIO) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored2013 Bitcoin miner reveals his trading system (free)There are 18,347 cryptocurrencies in the market right now. 99% of them will fail. And trying to pick winner...Crypto Swap Profits | SponsoredTrump’s new AI budget just passed — one stock could soarIn a quiet move few people noticed... President Trump just green-lit what could become the biggest AI budge...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Generation Bio Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Generation Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GBIO Stock Alerts